FDA Approves Wegovy for Cardiovascular Risk Reduction

The injection becomes the first weight loss medication to address life-threatening cardiovascular events. The Food and Drug Administration has expanded the approved use of Wegovy (semaglutide) injection, making…

Read More

Back to top
FE3